MCO-010 improves vision in retinitis pigmentosa through 4 years

NEW ORLEANS — An optogenetic therapy helped patients with retinitis pigmentosa maintain vision gains through 4 years, according to a study presented at the American Academy of Ophthalmology meeting.
“Optogenetics is a huge future potential for patients with low vision and irreversible vision loss,” Kenneth C. Fan, MD, MBA, of Retina Consultants of Texas, told Healio. “Retinitis pigmentosa causes slow, progressive vision loss over time. Patients are often legally blind in their 30s and 40s, so it’s a very tragic disease with no current treatment.”
{{VIDEO}}
Fan said REMAIN is the long-term

Why age matters in tax-efficient giving

A conversation with two clients recently reinforced an important lesson about charitable giving: The best way to donate is rarely the same for everyone.
The clients were a mother in her 70s and her daughter in her 30s. Both were financially successful. Both supported the same charitable organizations. Both planned to give the same dollar amounts.
Yet I recommended completely different giving strategies.
At first glance, that sounds odd. If the amount and charities are identical, shouldn’t the tax strategy be identical as well?
Not necessarily.
The most effective charitable giving strategy is not

Unauthorized marketing most common cause for aesthetic energy-based device recalls

SAN DIEGO — Laser and light devices accounted for 64% of all aesthetic energy-based device recalls in the U.S. during the past 24 years, though none were classified as the most serious recall type issued by the FDA, according to a speaker.
The FDA designated most of the recalls as class II, indicating potential “temporary or medically reversible adverse health consequences,” Melissa A. Levoska, MD, a dermatologist at UnionDerm, said during a presentation at the American Society for Dermatologic Surgery Annual Meeting. The most common cause for a recall was regulatory or unauthorized marketing,

CT plus AI found silent, untreated plaque in many ex-NFL players

CHICAGO — Many former NFL players, particularly linemen, have undiagnosed, untreated coronary artery disease without showing symptoms, according to results from coronary CT scans paired with AI plaque analysis.
Coronary CT angiography plus AI coronary plaque analysis (Heartflow Plaque Analysis) increased CAD awareness and willingness to initiate lipid-lowering therapy among retired NFL players, according to data presented at the American Heart Association Scientific Sessions.
“CVD is a well-documented concern for retired NFL players, with up to one in three dying from it, yet

Mindfulness, tai chi improve fatigue, pain after cancer treatment

Mindfulness-based cancer recovery and tai chi and qigong equally and significantly improve fatigue and pain for patients with cancer who have completed therapy.
The Mindfulness and Tai Chi for Cancer Health study also showed giving patients the choice of intervention may impact the effectiveness of care.
“People are looking for alternatives in mind-body therapies, where they can manage these symptoms without having to take drugs like painkillers or sleeping medications,” Linda E. Carlson, PhD, Enbridge Research Chair in Psychosocial Oncology and professor at University of Calgary, told Healio.

First-in-class therapy may improve clinical remission in ulcerative colitis

A receptor-interacting protein kinase 2 scaffolding inhibitor significantly improved clinical remission in moderately to severely active ulcerative colitis, according to results presented at United European Gastroenterology Week.
OD-001 (Odyssey Therapeutics) is a first-in-class RIPK2 scaffolding inhibitor that has previously achieved clinical proof of concept in patients with moderately to severely active ulcerative colitis.
Bruce E. Sands, MD, MS, FACG, Dr. Burril B. Crohn Professor of Medicine at Icahn School of Medicine at Mount Sinai, and colleagues conducted a phase 2a trial to evaluate

Current screening minimizes risk for early-onset MASLD cirrhosis

A distinct combination of factors — type 2 diabetes, obesity and high genetic risk score — may increase the risk for early-onset cirrhosis caused by metabolic dysfunction-associated liver disease, according to prospective study results.
Findings also showed that age-dependent screening tools like Fibrosis-4 index may overlook MASLD-related cirrhosis in adults younger than 50 years.
“Cirrhosis is often considered a disease of older adults, yet we increasingly encounter patients developing advanced MASLD before age 50,” Rohit Loomba, MD, MHSc, study author and director of

Weight loss with GLP-1s linked to improved rheumatoid arthritis

ORLANDO — Patients who lost weight using GLP-1 receptor agonists demonstrated clinically meaningful improvements in rheumatoid arthritis and psoriatic arthritis disease outcomes, according to data presented at ACR Convergence.
“Our focus is going to be on obesity in RA and PsA,” Nicholas McCormick, BS, a researcher and data scientist at the Foundation for Advancing Science, Technology, Education and Research, based in Alabama, told attendees. “We know that obesity is quite prevalent in both of these patient populations.”
To examine the links between 12-month weight

HAE attacks fall for children with prophylactic lanadelumab

PHOENIX — Pediatric patients with hereditary angioedema experienced fewer attacks with prophylactic lanadelumab, according to data presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Caregivers were satisfied with treatment as well, Priscilla Driscoll Shempp, MBA, clinical research strategist, Takeda Pharmaceuticals USA, and colleagues wrote.
“For many pediatric patients with HAE, long-term prophylaxis — or LTP — is used to achieve disease control and reduce attack burden,” Driscoll Shempp said during her presentation.